Shanghai Sunland Industrial Co., Ltd is the top manufacturer of Personal Protect Equipment in China, with 20 years’experience. We are the Chinese government appointed manufacturer for government power,personal protection equipment , medical instruments,construction industry, etc. All the products get the CE, ANSI and related Industry Certificates. All our safety helmets use the top-quality raw material without any recycling material.
Can individuals send protective clothing abroad
We provide exclusive customization of the products logo, using advanced printing technology and technology, not suitable for fading, solid and firm, scratch-proof and anti-smashing, and suitable for various scenes such as construction, mining, warehouse, inspection, etc. Our goal is to satisfy your needs. Demand, do your best.
Professional team work and production line which can make nice quality in short time.
The professional team provides 24 * 7 after-sales service for you, which can help you solve any problems
12/1/2020, · The cluster was initially reported on 31 December 2019, when the WHO China Country Office was informed. The Chinese authorities identified a new type of ,coronavirus, (,novel coronavirus,, nCoV), which was isolated on 7 January 2020. Laboratory testing was conducted on all suspected cases identified through active case finding and retrospective review.
The 2019 ,novel coronavirus, (,COVID-19,, also known as 2019-nCoV) outbreak in Wuhan, China is rapidly approaching a pandemic as the number of countries with victims continues to grow. As of February 10, 2020, over 40,000 cases have been reported worldwide ( REF: WHO situation reports ).
Novel Coronavirus, (,COVID-19,) is a new strain of ,coronavirus, which may cause illness in animals or humans. In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases. First identified in a cluster with pneumonia symptoms in Wuhan city, Hubei province of China.
The antibody detection offers vital clinical information during the course of SARS-CoV-2 infection. The findings provide strong empirical support for the routine ,application, of serological testing in the diagnosis and management of ,COVID-19, patients.
In another recent ,application, brought by Arthur Cox on behalf of its client, the High Court considered the operation of section 204 of the Act, which provides for the reduction in company capital carried out using the Summary Approval Procedure ("SAP") - a streamlined procedure available to a company to authorise various types of activities, such as a reduction of company capital, which would ...
Right now there is no vaccine available to protect against ,novel coronavirus,, but several versions of a vaccine are being tested to see if they work to prevent ,COVID-19, and are safe for humans. I was a close contact to a case of ,COVID-19, and was asked to self-quarantine.